SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 12, 2004
eXegenics Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 00-26078 | 75-2402409 | ||
| (State or Other Jurisdiction | (Commission | (I.R.S. Employer | ||
| of Incorporation) | File Number) | Identification No.) |
1250 Pittsford-Victor Road
Building 200, Suite 280
Pittsford, New York 14534
(Address of principal executive
offices including zip code)
(585) 218-4368
(Registrant’s telephone number,
including area code)
(Former name or former address, if changed since last report)
| SECURITIES AND EXCHANGE COMMISSION | ||||||||
| WASHINGTON, D.C. 20549 | ||||||||
| FORM 8-K | ||||||||
| SIGNATURES | ||||||||
Section 3 — Securities and Trading Markets
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On October 12, 2004, the Company received a letter from NASDAQ stating that the Company’s securities will be delisted from The Nasdaq Stock Market effective with the open of trading on Thursday, October 14, 2004. The Company’s securities will not be immediately eligible to trade on the OTC Bulletin Board given that the Panel has determined that such delisting was based upon concerns under Nasdaq Marketplace Rule 4330. The Company is working diligently to have its common stock trading on the OTC Bulletin Board.